These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6191240)

  • 1. Partial blockade of neurotensin-induced hypotension in rats by nephrectomy captopril and saralasin. Possible mechanisms.
    Kérouac R; St-Pierre S; Manning M; Rioux F
    Neuropeptides; 1983 Apr; 3(4):295-307. PubMed ID: 6191240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
    Hutchinson JS; Mendelsohn FA; Doyle AE
    Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of captopril induced hypotension in rats.
    Clarke DE; Wagner LB; Wagner LA
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of various drugs on the variations of blood pressure, hematocrit and plasma histamine caused by neurotensin and compound 48/80 in rats.
    Kérouac R; St-Pierre S; Rioux F
    Neuropeptides; 1982 Dec; 3(2):145-57. PubMed ID: 6131390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inhibitory effect of [D-Trp11]-NT toward some biological actions of neurotensin in rats.
    Rioux F; Kérouac R; St-Pierre S
    Neuropeptides; 1983 Jul; 3(5):345-54. PubMed ID: 6194472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of captopril in relation to plasma renin activity in anesthetized rats.
    Satoh S; Suzuki M; Satoh H
    J Pharmacobiodyn; 1980 May; 3(5):258-60. PubMed ID: 6997455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
    Marks ES; Bing RF; Thurston H; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential prejunctional effect of captopril and saralasin on neurogenic vasoconstriction in pithed normotensive rats.
    De Jonge A; Wilffert B; Thoolen MJ; Timmermans PB; van Zwieten PA
    Life Sci; 1984 Apr; 34(15):1433-9. PubMed ID: 6369059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
    Antonaccio MJ; Kerwin L
    Hypertension; 1981; 3(3 Pt 2):I54-62. PubMed ID: 6167515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypotensive effect of centrally administered neurotensin in rats.
    Rioux F; Quirion R; St-Pierre S; Regoli D; Jolicoeur FB; Bélanger F; Barbeau A
    Eur J Pharmacol; 1981 Jan; 69(3):241-7. PubMed ID: 7215426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
    Baker KM; Johns DW; Vaughan ED; Ayers CR; Carey RM
    Clin Exp Hypertens (1978); 1980; 2(6):947-54. PubMed ID: 7004807
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225).
    Weed WC; Vaughan ED; Peach MJ
    Hypertension; 1979; 1(1):8-12. PubMed ID: 397195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between coronary occlusion and the renin-angiotensin system in the dog.
    Ertl G; Alexander RW; Kloner RA
    Basic Res Cardiol; 1983; 78(5):518-33. PubMed ID: 6360140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressor responses of rats to vasopressin: effect of sodium, angiotensin, and catecholamines.
    Burnier M; Brunner HR
    Am J Physiol; 1983 Feb; 244(2):H253-8. PubMed ID: 6337508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction.
    Clough DP; Hatton R; Keddie JR; Collis MG
    Hypertension; 1982; 4(6):764-72. PubMed ID: 6292083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
    Kaukinen S; Kataja J; Ylitalo P
    Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of histamine and adrenaline in vivo following intravenous administration of neurotensin.
    Oishi M; Ishiko J; Inagaki C; Takaori S
    Life Sci; 1983 May; 32(19):2231-9. PubMed ID: 6405112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.